Free Trial

BioRestorative Therapies (BRTX) Earnings Date, Estimates & Call Transcripts

BioRestorative Therapies logo
$1.40 +0.01 (+0.72%)
(As of 11/20/2024 ET)

BioRestorative Therapies Latest Earnings Summary

Upcoming
Earnings Date
Apr. 4Estimated
Actual EPS
(Nov. 12)
-$0.13 Beat By $0.22
Consensus EPS
(Nov. 12)
-$0.35

BioRestorative Therapies released Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.13, which beat the consensus estimate of -$0.35 by $0.22. Quarterly revenue was reported to be $0.23 million, below analysts' expectations of $0.30 million. With a trailing EPS of -$1.53, BioRestorative Therapies' earnings are expected to grow next year, from ($1.43) to ($0.86) per share.

BRTX Upcoming Earnings

BioRestorative Therapies' next earnings date is estimated for Friday, April 4, 2025, based off prior year's reporting schedules.

Get BioRestorative Therapies Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioRestorative Therapies and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

BRTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BRTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BioRestorative Therapies Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20241-$0.51-$0.51-$0.51
Q2 20241-$0.56-$0.56-$0.56
Q3 20241-$0.35-$0.35-$0.35
Q4 20241-$0.27-$0.27-$0.27
FY 20244-$1.69-$1.69-$1.69
Q1 20251-$0.26-$0.26-$0.26
Q2 20251-$0.20-$0.20-$0.20
Q3 20251-$0.20-$0.20-$0.20
Q4 20251-$0.21-$0.21-$0.21
FY 20254($0.87)($0.87)($0.87)

BioRestorative Therapies Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
4/4/2025
(Estimated)
------- 
11/12/2024--$0.35-$0.13+$0.22-$0.13$0.30M$0.23M
8/13/2024Q2 2024-$0.56-$0.50+$0.06-$0.50$0.03M$0.09M
6/11/2024Q1 2024-$0.51-$0.53 -$0.02-$0.73$0.03M$0.04M
3/29/2024Q4 2023--$0.57 -$0.57-$0.57$0.03M$0.02M
11/13/2023Q3 2023-$0.68-$0.64+$0.04-$0.64$0.03M$0.03M
8/11/2023Q2 2023-$1.56-$0.77+$0.79-$0.77$0.03M$0.07M
5/12/2023Q1 2023-$1.26-$1.53 -$0.27-$1.53$0.03M$0.03M
3/24/2023Q4 2022--$1.18 -$1.18-$1.18--

BioRestorative Therapies Earnings - Frequently Asked Questions

BioRestorative Therapies has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, April 4th, 2025 based off last year's report dates. Learn more on BRTX's earnings history.

In the previous quarter, BioRestorative Therapies (NASDAQ:BRTX) reported ($0.13) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.35) by $0.22. Learn more on analysts' earnings estimate vs. BRTX's actual earnings.

BioRestorative Therapies (NASDAQ:BRTX) has a recorded annual revenue of $150,000.00.

BioRestorative Therapies (NASDAQ:BRTX) has a recorded net income of -$14.41 million. BRTX has generated -$1.53 earnings per share over the last four quarters.

BioRestorative Therapies's earnings are expected to grow from ($1.43) per share to ($0.86) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:BRTX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners